Nanocarriers: a versatile approach for mucosal vaccine delivery

Area of Science:

• Immunology
• Vaccinology
• Nanotechnology

Background:

• Infectious agents frequently enter the body via mucosal surfaces, underscoring the need for effective mucosal vaccines.
• Conventional parenteral vaccination often fails to induce robust mucosal immunity, necessitating alternative delivery strategies.
• Vaccine safety, cost-effectiveness, and stability are paramount for widespread adoption and efficacy.

Purpose of the Study:

• To review the challenges associated with developing and administering mucosal vaccines.
• To evaluate the potential of nanocarriers as delivery systems for mucosal vaccines.
• To discuss factors influencing nanocarrier performance and their current clinical standing.

Main Methods:

• Literature review focusing on mucosal vaccine challenges.
• Analysis of nanocarrier applications in vaccine delivery.
• Examination of factors affecting nanocarrier-based mucosal vaccine efficacy.
• Review of the clinical status of nanocarrier vaccine systems.

Main Results:

• Mucosal vaccination offers a promising route for eliciting targeted immune responses.
• Nanocarriers present a viable solution for overcoming challenges in antigen delivery and stability for mucosal vaccines.
• Several factors, including particle size, surface charge, and targeting ability, influence nanocarrier performance.
• The clinical progression of nanocarrier-based vaccine systems is an active area of research and development.

Conclusions:

• Nanocarriers show significant promise for enhancing the efficacy and stability of mucosal vaccines.
• Addressing the challenges in nanocarrier design and evaluation is key to advancing mucosal vaccine technology.
• Further clinical investigation is required to fully realize the potential of nanocarrier-based mucosal vaccines.